Prevalence of Cancer in Patients with Venous Thromboembolism: A Retrospective Nationwide Case-Control Study in Sweden

Overview

Journal Clin Appl Thromb Hemost

Publisher Sage Publications

Specialty Cardiology & Vascular Diseases

Date 2023 Feb 28

PMID 36851858

Authors

Katarina Glise Sandblad

Per-Olof Hansson

Jacob Philipson

Ahmad Mahmoud

Per Karlsson

Annika Rosengren

Jan Sorbo

Affiliations

Soon will be listed here.

Abstract

Cancer is a risk factor for venous thromboembolism (VTE). We aimed to define sex-specific risk of preceding cancer in patients with a first-time VTE by conducting a nationwide Swedish registry-based study including 298 172 patients with VTE and 1 185 079 matched controls. This included 44 685 patients with a diagnosis of cancer at/or within 1 year before a VTE diagnosis. Female patients with VTE had a higher multivariable adjusted odds ratios of preceding cancer than male patients with VTE (5.5 [99% confidence interval 5.4-5.7] vs 3.9 [3.8-4.0]). The highest risk of cancer in patients with VTE were found for pancreatic cancer (women: 19.6 [15.8-24.4]; men: 17.2 [13.7-21.6]) and brain cancer (women: 17.4 [12.9-23.4]; men: 17.5 [13.8-22.2]). Weak associations were seen between VTE and bladder/urothelial cancer (women: 1.31 [1.12-1.53]; men: 1.34 [1.23-1.47]), prostate cancer (men: 2.17 [2.07-2.27]), malignant melanoma (women: 2.51 [2.07-3.05]; men: 2.67 [2.23-3.18]), and kidney cancer (women: 3.20 [2.49-4.11]; men: 3.33 [2.79-4.07]). In conclusion, associations with VTE were weak for bladder/urothelial cancer and kidney cancer, and strong for pancreatic, brain, and biliary cancers.

Citing Articles

The impact of preoperative venous thromboembolism on patients undergoing TURBT: Perioperative outcomes and healthcare costs from US insurance claims data.

Tresh A, Del Giudice F, Li S, Basran S, De Berardinis E, Carino D BJUI Compass. 2025; 6(1):e481.

PMID: 39877570 PMC: 11771507. DOI: 10.1002/bco2.481.

High Rate of Thromboembolic Events in the Last Year of Life of Cancer Patients: A Registry Study.

Strang P, Schultz T Cancers (Basel). 2024; 16(23).

PMID: 39682217 PMC: 11640034. DOI: 10.3390/cancers16234031.

Reassessing the Risk of Venous Thromboembolism (VTE) Events in Women.

He C, Chu J, Li Y, Dang Y, Xue K, Cai C Clin Appl Thromb Hemost. 2024; 30:10760296241305108.

PMID: 39648738 PMC: 11626654. DOI: 10.1177/10760296241305108.

A commentary on 'Risk factors for incident venous thromboembolism in patients with renal tumor and inferior vena cava tumor thrombus: A retrospective case-control study'.

Feng J, Cao Y, Wei J Int J Surg. 2024; 110(4):2440-2441.

PMID: 38668667 PMC: 11020018. DOI: 10.1097/JS9.0000000000001059.

The Impact of Venous Thromboembolism on Upper Tract Urothelial Carcinomas Undergoing Open or Minimally Invasive Radical Nephroureterectomy in the USA: Perioperative Outcomes and Health Care Costs from Insurance Claims Data.

Tresh A, Del Giudice F, Li S, Basran S, Belladelli F, De Berardinis E Eur Urol Focus. 2024; 10(2):317-324.

PMID: 38433067 PMC: 11602270. DOI: 10.1016/j.euf.2024.02.004.

References

Khorana A, Kuderer N, Culakova E, Lyman G, Francis C . Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008; 111(10):4902-7. PMC: 2384124. DOI: 10.1182/blood-2007-10-116327. View

Streiff M, Holmstrom B, Angelini D, Ashrani A, Elshoury A, Fanikos J . Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021; 19(10):1181-1201. DOI: 10.6004/jnccn.2021.0047. View

Cronin-Fenton D, Sondergaard F, Pedersen L, Fryzek J, Cetin K, Acquavella J . Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006. Br J Cancer. 2010; 103(7):947-53. PMC: 2965880. DOI: 10.1038/sj.bjc.6605883. View

Lyman G, Eckert L, Wang Y, Wang H, Cohen A . Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis. Oncologist. 2013; 18(12):1321-9. PMC: 3868427. DOI: 10.1634/theoncologist.2013-0226. View

Khorana A, Francis C, Culakova E, Kuderer N, Lyman G . Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer. 2007; 110(10):2339-46. DOI: 10.1002/cncr.23062. View

Chew H, Wun T, Harvey D, Zhou H, White R . Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med. 2006; 166(4):458-64. DOI: 10.1001/archinte.166.4.458. View

Khorana A, Dalal M, Lin J, Connolly G . Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States. Cancer. 2012; 119(3):648-55. DOI: 10.1002/cncr.27772. View

Glise Sandblad K, Rosengren A, Sorbo J, Jern S, Hansson P . Pulmonary embolism and deep vein thrombosis-comorbidities and temporary provoking factors in a register-based study of 1.48 million people. Res Pract Thromb Haemost. 2022; 6(4):e12714. PMC: 9166387. DOI: 10.1002/rth2.12714. View

Blom J, Doggen C, Osanto S, Rosendaal F . Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005; 293(6):715-22. DOI: 10.1001/jama.293.6.715. View

10.

Abdul Sultan A, West J, Stephansson O, Grainge M, Tata L, Fleming K . Defining venous thromboembolism and measuring its incidence using Swedish health registries: a nationwide pregnancy cohort study. BMJ Open. 2015; 5(11):e008864. PMC: 4654387. DOI: 10.1136/bmjopen-2015-008864. View

11.

Khorana A, Francis C, Culakova E, Fisher R, Kuderer N, Lyman G . Thromboembolism in hospitalized neutropenic cancer patients. J Clin Oncol. 2006; 24(3):484-90. DOI: 10.1200/JCO.2005.03.8877. View

12.

Rosengren A, Freden M, Hansson P, Wilhelmsen L, Wedel H, Eriksson H . Psychosocial factors and venous thromboembolism: a long-term follow-up study of Swedish men. J Thromb Haemost. 2007; 6(4):558-64. DOI: 10.1111/j.1538-7836.2007.02857.x. View

13.

Scomersi S, Giudici F, Cacciatore G, Losurdo P, Fracon S, Cortinovis S . Comparison between male and female breast cancer survival using propensity score matching analysis. Sci Rep. 2021; 11(1):11639. PMC: 8172634. DOI: 10.1038/s41598-021-91131-4. View

14.

Khorana A, Mackman N, Falanga A, Pabinger I, Noble S, Ageno W . Cancer-associated venous thromboembolism. Nat Rev Dis Primers. 2022; 8(1):11. DOI: 10.1038/s41572-022-00336-y. View

15.

Walker A, Card T, West J, Crooks C, Grainge M . Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases. Eur J Cancer. 2012; 49(6):1404-13. DOI: 10.1016/j.ejca.2012.10.021. View

16.

Chuang L, Gumbs P, van Hout B, Agnelli G, Kroep S, Monreal M . Health-related quality of life and mortality in patients with pulmonary embolism: a prospective cohort study in seven European countries. Qual Life Res. 2019; 28(8):2111-2124. PMC: 6620245. DOI: 10.1007/s11136-019-02175-z. View

17.

Khorana A, Dalal M, Lin J, Connolly G . Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States. Clinicoecon Outcomes Res. 2013; 5:101-8. PMC: 3575127. DOI: 10.2147/CEOR.S39964. View

18.

Sorensen H, Mellemkjaer L, Olsen J, Baron J . Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000; 343(25):1846-50. DOI: 10.1056/NEJM200012213432504. View

19.

Lyman G, Carrier M, Ay C, Di Nisio M, Hicks L, Khorana A . American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv. 2021; 5(4):927-974. PMC: 7903232. DOI: 10.1182/bloodadvances.2020003442. View

20.

Grilz E, Posch F, Nopp S, Konigsbrugge O, Lang I, Klimek P . Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer-a nationwide analysis. Eur Heart J. 2021; 42(23):2299-2307. DOI: 10.1093/eurheartj/ehab171. View